BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37718491)

  • 1. Model-informed precision dosing of vancomycin for rapid achievement of target area under the concentration-time curve: A simulation study.
    Oda K; Yamada T; Matsumoto K; Hanai Y; Ueda T; Samura M; Shigemi A; Jono H; Saito H; Kimura T
    Clin Transl Sci; 2023 Nov; 16(11):2265-2275. PubMed ID: 37718491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration-time curve: A simulation study.
    Oda K; Yamada T; Matsumoto K; Hanai Y; Ueda T; Samura M; Shigemi A; Jono H; Saito H; Kimura T
    Clin Transl Sci; 2023 Apr; 16(4):704-713. PubMed ID: 36748688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A simulation study on model-informed precision dosing of amikacin for achieving target area under the concentration-time curve.
    Yamada T; Oda K; Nishihara M; Neo M
    Br J Clin Pharmacol; 2024 Apr; 90(4):1173-1182. PubMed ID: 38304967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population.
    Duong A; El Gamal A; Bilodeau V; Huot J; Delorme C; Poudrette J; Crevier B; Marsot A
    Pharmacotherapy; 2024 Jun; 44(6):425-434. PubMed ID: 38803279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of model-informed precision dosing on achievement of vancomycin exposure targets in pediatric patients with cystic fibrosis.
    Frymoyer A; Schwenk HT; Brockmeyer JM; Bio L
    Pharmacotherapy; 2023 Oct; 43(10):1007-1014. PubMed ID: 37401162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized Delivery of Vancomycin by Model-Informed Bayesian Dosing Approach to Maintain an AUC24 Target in Critically Ill Patients.
    Rao Z; Guo SM; Wei YM
    Chemotherapy; 2024; 69(1):49-55. PubMed ID: 37591210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does calculation method matter for targeting vancomycin area under the curve?
    Chang J; Patel D; Vega A; Claeys KC; Heil EL; Scheetz MH
    J Antimicrob Chemother; 2022 Jul; 77(8):2245-2250. PubMed ID: 35640658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L; Wong T; Huang S; Mui E; Nguyen V; Espinosa G; Desai J; Holubar M; Deresinski S
    Pharmacotherapy; 2019 Apr; 39(4):433-442. PubMed ID: 30739349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic equations versus Bayesian guided vancomycin monitoring: Pharmacokinetic model and model-informed precision dosing trial simulations.
    Aljutayli A; Thirion DJG; Bonnefois G; Nekka F
    Clin Transl Sci; 2022 Apr; 15(4):942-953. PubMed ID: 35170243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward Model-Based Informed Precision Dosing of Vancomycin in Hematologic Cancer Patients: A First Step.
    Le Blanc J; Projean D; Savignac S; Léveillé S; Ducas MP; Brisebois-Boyer A; Marsot A
    Clin Pharmacokinet; 2024 Feb; 63(2):183-196. PubMed ID: 38127240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards precision dosing of vancomycin: a systematic evaluation of pharmacometric models for Bayesian forecasting.
    Broeker A; Nardecchia M; Klinker KP; Derendorf H; Day RO; Marriott DJ; Carland JE; Stocker SL; Wicha SG
    Clin Microbiol Infect; 2019 Oct; 25(10):1286.e1-1286.e7. PubMed ID: 30872102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Bayesian Area Under the Concentration-Time Curve-Based Pharmacokinetic Dosing Based on a One-Compartment Model and Trough-Only Monitoring for Vancomycin.
    Salehpour N; Riley LD; Gonzales MJ; Kobic E; Nix DE
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0017223. PubMed ID: 37133362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT; Steele JM; Seabury RW; Dang UJ; Kufel WD
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the mathematical equation and trapezoidal approach for 24 h area under the plasma concentration-time curve calculation in patients who received intravenous vancomycin in an acute care setting.
    Chanapiwat P; Paiboonvong T; Rattanaumpawan P; Montakantikul P
    Pharmacol Res Perspect; 2023 Feb; 11(1):e01046. PubMed ID: 36588162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring.
    Aljutayli A; Thirion DJG; Nekka F
    Biomed Pharmacother; 2022 Nov; 155():113777. PubMed ID: 36271558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vancomycin area under the concentration-time curve (AUC) using two-point pharmacokinetics versus two open-access online single-concentration vancomycin calculators.
    Ondrush NM; Ademovic R; Seabury RW; Darko W; Miller CD; Mogle BT
    J Clin Pharm Ther; 2022 Dec; 47(12):2223-2229. PubMed ID: 36351763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Trough Concentration of Vancomycin Predictive of the Area Under the Curve? A Clinical Study in Elderly Patients.
    Bel Kamel A; Bourguignon L; Marcos M; Ducher M; Goutelle S
    Ther Drug Monit; 2017 Feb; 39(1):83-87. PubMed ID: 27861313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing Vancomycin Use Through 2-Point AUC-Based Therapeutic Drug Monitoring in Pediatric Patients.
    Suchartlikitwong P; Anugulruengkitt S; Wacharachaisurapol N; Jantarabenjakul W; Sophonphan J; Theerawit T; Chatsuwan T; Wattanavijitkul T; Puthanakit T
    J Clin Pharmacol; 2019 Dec; 59(12):1597-1605. PubMed ID: 31342543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.
    Prybylski JP
    Clin Pharmacokinet; 2017 Mar; 56(3):263-272. PubMed ID: 27389404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.